Competing chaperone pathways in α‐synuclein disaggregation and aggregation dynamics

The aggregation of the protein α-synuclein into amyloid fibrils and their subsequent deposition into large proteinaceous inclusions is a pathological hallmark of several neurodegenerative diseases, including Parkinson's disease. Molecular chaperones, including the small heat-shock proteins (sHsps) and the Hsp70 chaperone system, are known to interact with α-synuclein fibrils, preventing further aggregation and disaggregating fibrillar species, respectively. However, it remains unclear if sHsps co-operate with the Hsp70 chaperones to potentially improve the kinetics or effectiveness of Hsp70-mediated disaggregation and how disaggregation kinetics are influenced by aggregation-prone α-synuclein monomers. Using thioflavin-T assays, we demonstrate that the sHsps Hsp27 (HSPB1) and αB-crystallin (HSPB5) do not synergize with the Hsp70 chaperones during α-synuclein seed fibril disaggregation. Moreover, the addition of monomeric α-synuclein with fibril seeds results in increased aggregation that overwhelms Hsp70-mediated disaggregation. Overall, these results suggest that while Hsp70 and sHsp chaperones are independently capable of binding to and inhibiting fibril elongation, they do not have synergistic effects on disaggregation. Furthermore, Hsp70-mediated disaggregation is ineffectual in the presence of physiological concentrations of α-synuclein monomers, conditions that actually lead to further α-synuclein aggregation. Overall, these data may offer insight into factors that lead to the failure of the Hsp70 chaperones to clear cells of α-synuclein aggregates that lead to neurodegenerative disease.

Authors

Institutions

Publication Details

Journal
Protein Science
Published
2025-09-13
DOI
https://doi.org/10.1002/pro.70296
Citations
2
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
2.78

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Competing chaperone pathways in α‐synuclein disaggregation and aggregation dynamics

Nicholas R. Marzano, Shannon McMahon, Antoine M. van Oijen, Heath Ecroyd et al.
2 citations
Protein Science
Parkinson's Disease Mechanisms and Treatments
2.78
article

Competing chaperone pathways in α‐synuclein disaggregation and aggregation dynamics

Nicholas R. Marzano, Shannon McMahon, Antoine M. van Oijen, Heath Ecroyd, Nicola K. Auld
article en
2 citations

Abstract

The aggregation of the protein α-synuclein into amyloid fibrils and their subsequent deposition into large proteinaceous inclusions is a pathological hallmark of several neurodegenerative diseases, including Parkinson's disease. Molecular chaperones, including the small heat-shock proteins (sHsps) and the Hsp70 chaperone system, are known to interact with α-synuclein fibrils, preventing further aggregation and disaggregating fibrillar species, respectively. However, it remains unclear if sHsps co-operate with the Hsp70 chaperones to potentially improve the kinetics or effectiveness of Hsp70-mediated disaggregation and how disaggregation kinetics are influenced by aggregation-prone α-synuclein monomers. Using thioflavin-T assays, we demonstrate that the sHsps Hsp27 (HSPB1) and αB-crystallin (HSPB5) do not synergize with the Hsp70 chaperones during α-synuclein seed fibril disaggregation. Moreover, the addition of monomeric α-synuclein with fibril seeds results in increased aggregation that overwhelms Hsp70-mediated disaggregation. Overall, these results suggest that while Hsp70 and sHsp chaperones are independently capable of binding to and inhibiting fibril elongation, they do not have synergistic effects on disaggregation. Furthermore, Hsp70-mediated disaggregation is ineffectual in the presence of physiological concentrations of α-synuclein monomers, conditions that actually lead to further α-synuclein aggregation. Overall, these data may offer insight into factors that lead to the failure of the Hsp70 chaperones to clear cells of α-synuclein aggregates that lead to neurodegenerative disease.

Protein ScienceVol. 34(10)
The University of Sydney (AU), University of Wollongong (AU)
University of Wollongong, Medical Research Council, National Health and Medical Research Council
Openalex Percentile: Top 9%
Parkinson's Disease Mechanisms and Treatments
2.78
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.